BioCentury
ARTICLE | Company News

Adeza other research news

October 14, 1996 7:00 AM UTC

Adeza received a $100,000 Phase I STTR to develop an assay to measure anti-ovarian antibodies, which are associated with poor response to ovulation induction by gonadotropin administration. The test c...